Results 71 to 80 of about 2,494 (91)
Some of the next articles are maybe not open access.
Bloch–Sulzberger syndrome (Incontinentia pigmenti)
Russian Journal of Skin and Venereal Diseases, 2023Bloch–Sulzberger syndrome or Incontinentia pigmenti is a genetic disease that causes skin pathology in the first days of a child's life and is suspected of identifying the disease.
S. N. Shchava, Marina A. Shishkina
semanticscholar +1 more source
An atypical case of incontinentia pigmenti with a hypomorphic variant
Pediatric dermatology, 2023Incontinentia pigmenti (IP) is a rare X‐linked dominant genodermatosis that affects skin, hair, teeth, eyes and central nervous system. We present the case of a female patient with mild IP caused by a hypomorphic pathogenic variant of the inhibitor of ...
Youming Guo +4 more
semanticscholar +1 more source
Incontinentia pigmenti and the eye
Current Opinion in Ophthalmology, 2022Purpose of Review: Incontinentia pigmenti (IP) is a rare X-linked dominant phakomatosis that predominately presents with dermatologic manifestations but can also cause central nervous system and ocular abnormalities. Awareness of the ocular complications
Y. Islam, S. Khurshid
semanticscholar +1 more source
Neurology(R) neuroimmunology & neuroinflammation
Background and Objectives DNA variations in the NF-kappa-B essential modulator (NEMO) gene are linked to incontinentia pigmenti (IP) and also immunodeficiency and autoinflammatory conditions.
S. Mohammad +8 more
semanticscholar +1 more source
Background and Objectives DNA variations in the NF-kappa-B essential modulator (NEMO) gene are linked to incontinentia pigmenti (IP) and also immunodeficiency and autoinflammatory conditions.
S. Mohammad +8 more
semanticscholar +1 more source
Whole Exome Sequencing in Incontinentia Pigmenti: A ROP Mimicker and the Genetic Detection Dilemma.
Journal of pediatric ophthalmology and strabismusIncontinentia pigmenti is an X-linked dominant multisystemic disorder caused by pathogenic variants in the inhibitor of nuclear factor kappa B kinase regulatory subunit gamma (IKBKG) gene.
Hema Duraiswamy +4 more
semanticscholar +1 more source
Retinal cases & brief reports, 2022
Depth-resolved investigational handheld optical coherence tomography imaging in a child with incontinentia pigmenti revealed localized retinal thinning with concurrent capillary flow loss and diving of superficial retinal vessels as they traversed from ...
Pujan R. Patel +6 more
semanticscholar +1 more source
Depth-resolved investigational handheld optical coherence tomography imaging in a child with incontinentia pigmenti revealed localized retinal thinning with concurrent capillary flow loss and diving of superficial retinal vessels as they traversed from ...
Pujan R. Patel +6 more
semanticscholar +1 more source
Incontinentia Pigmenti In A Male Infant: A Case Report
Berkala Ilmu Kesehatan Kulit dan KelaminBackground: Incontinentia pigmenti (IP), also known as Bloch-Sulzberger syndrome, is a rare X-linked dominant genodermatosis with an estimated incidence of 0.7–1.2 per 100,000 live births. It is caused by mutations in the IKBKG gene.
Arifiana Wungu +7 more
semanticscholar +1 more source
NEONATAL INCONTINENTIA PIGMENTI – A CASE REPORT
Academic Medical JournalIncontinentia pigmenti or Bloch-Sulzberger syndrome, is a rare multisystem, X-linked dominant disorder that most commonly occurs in female newborns. It is usually lethal, and most pregnancies with male fetuses result in miscarriage or stillbirth, while ...
Milena Kacarska Mickoska +2 more
semanticscholar +1 more source
Incontinentia pigmenti underlies thymic dysplasia, autoantibodies to type I IFNs, and viral diseases
Journal of Experimental MedicineHeterozygosity for null NEMO mutations underlies hypotrophic and dysplastic thymus in mice and humans. Women with incontinentia pigmenti therefore have a high prevalence of autoantibodies neutralizing type I interferons, which predisposes them to severe ...
J. Rosain +98 more
semanticscholar +1 more source
Ophthalmologic Presentations of Incontinentia Pigmenti
Journal of VitreoRetinal DiseasesPurpose: To characterize treatments and outcomes in incontinentia pigmenti. Methods: Cases of incontinentia pigmenti were consecutively identified from a retina practice. Inclusion criteria were patients with incontinentia pigmenti with at least 6 months
Ravneet Rai, Albert S. Li, P. Ferrone
semanticscholar +1 more source

